logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Pulmonology drugs

    FiltersReset Filters
    28 results

    • acthar

      (Repository Corticotropin)
      Mallinckrodt ARD LLC
      Usage: Acthar Gel is indicated for treating infantile spasms in infants, acute exacerbations of multiple sclerosis in adults, and various rheumatic disorders. It is also used for collagen diseases, severe dermatologic conditions, allergic states, specific ophthalmic and respiratory diseases, and to manage proteinuria in nephrotic syndrome.

    • adempas

      (riociguat)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Adempas is indicated for adults with chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatment or if inoperable, as well as for pulmonary arterial hypertension (PAH). It improves exercise capacity, WHO functional class, and delays clinical worsening. The drug is effective as monotherapy or in combination with other treatments.

    • advair

      (fluticasone propionate and salmeterol)
      GlaxoSmithKline LLC
      Usage: ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for acute bronchospasm relief or for patients not adequately controlled on long-term asthma medications.

    • advair hfa

      (fluticasone propionate and salmeterol xinafoate)
      GlaxoSmithKline LLC
      Usage: ADVAIR HFA is indicated for the treatment of asthma in adults and adolescents aged 12 and older who are not adequately controlled on long-term asthma medications or require both an inhaled corticosteroid and a long-acting beta2-adrenergic agonist. It is not for acute bronchospasm relief.

    • alvesco

      (ciclesonide)
      Covis Pharma US, Inc
      Usage: ALVESCO is indicated for the maintenance treatment of asthma in adults and pediatric patients aged 12 and older. It is not intended for the relief of acute bronchospasm or for children under 12 years of age.

    • anoro ellipta

      (umeclidinium bromide and vilanterol trifenatate)
      GlaxoSmithKline LLC
      Usage: ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.

    • arnuity ellipta

      (fluticasone furoate)
      GlaxoSmithKline LLC
      Usage: ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and children aged 5 years and older, but is not intended for the relief of acute bronchospasm.

    • avycaz

      (ceftazidime, avibactam)
      Allergan, Inc.
      Usage: AVYCAZ (ceftazidime and avibactam) is indicated for treating complicated intra-abdominal and urinary tract infections, including pyelonephritis, as well as hospital-acquired and ventilator-associated bacterial pneumonia. It targets susceptible gram-negative bacteria in adult and pediatric patients (≥31 weeks gestational age).

    • cinqair

      (Reslizumab)
      Teva Respiratory, LLC
      Usage: CINQAIR® is indicated as an add-on maintenance treatment for adults (18+) with severe asthma exhibiting an eosinophilic phenotype. It is not intended for other eosinophilic conditions or for acute bronchospasm relief or status asthmaticus.

    • cytalux

      (Pafolacianine injection)
      On Target Laboratories, Inc.
      Usage: CYTALUX is indicated as an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer and for both malignant and non-malignant pulmonary lesions in adult patients with known or suspected lung cancer.